Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 6:18 pm Sale | 2023-12-31 | 13G | Benitec Biopharma Inc. BNTC | Citadel Advisors LLC | 95,356 3.600% | -84,674 (-47.03%) | Filing History |
| 2024-02-14 10:00 am Sale | 2023-12-31 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 180,399 7.000% | -25,771 (-12.50%) | Filing History |
| 2024-02-13 5:16 pm Purchase | 2023-12-31 | 13G | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 262,843 9.990% | 262,843 (New Position) | Filing History |
| 2023-12-11 12:41 pm Purchase | 2023-11-30 | 13G | Benitec Biopharma Inc. BNTC | FRANKLIN RESOURCES INC BEN | 588,237 22.900% | 2 (+0.00%) | Filing History |
| 2023-09-11 11:27 am Purchase | 2023-08-31 | 13G | Benitec Biopharma Inc. BNTC | FRANKLIN RESOURCES INC BEN | 588,235 28.500% | 588,235 (New Position) | Filing History |
| 2023-08-25 4:30 pm Purchase | 2023-08-15 | 13G | Benitec Biopharma Inc. BNTC | ADAGE CAPITAL PARTNERS GP L.L.C. | 189,188 7.500% | 189,188 (New Position) | Filing History |
| 2023-08-21 4:07 pm Purchase | 2023-08-11 | 13G | Benitec Biopharma Inc. BNTC | Citadel Advisors LLC | 180,030 6.900% | 180,030 (New Position) | Filing History |
| 2023-08-18 3:55 pm Purchase | 2023-08-09 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 206,170 9.900% | 206,170 (New Position) | Filing History |
| 2023-08-18 10:50 am Sale | 2023-08-08 | 13G | Benitec Biopharma Inc. BNTC | Steven Michael Oliveira | 98,203 3.890% | -24,395 (-19.90%) | Filing History |
| 2023-04-18 4:16 pm Sale | 2022-12-31 | 13G | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 177,660 9.990% | -194,617 (-52.28%) | Filing History |
| 2023-02-14 11:24 am Sale | 2022-12-31 | 13G | Benitec Biopharma Inc. BNTC | CVI Investments, Inc. | 86,447 4.900% | -1,789 (-2.03%) | Filing History |
| 2023-02-13 12:25 pm Purchase | 2022-12-31 | 13G | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 372,276 9.990% | 327,041 (+722.98%) | Filing History |
| 2023-02-07 5:38 pm Sale | 2022-12-31 | 13G | Benitec Biopharma Inc. BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 0 0.000% | -34,559 (Position Closed) | Filing History |
| 2022-10-11 12:05 pm Purchase | 2022-09-30 | 13G | Benitec Biopharma Inc. BNTC | FRANKLIN RESOURCES INC BEN | 588,235 38.700% | 588,235 (New Position) | Filing History |
| 2022-10-07 12:46 pm Purchase | 2022-09-14 | 13G | Benitec Biopharma Inc. BNTC | Steven Michael Oliveira | 122,598 8.080% | 83,297 (+211.94%) | Filing History |
| 2022-09-23 10:11 am Purchase | 2022-09-13 | 13G | Benitec Biopharma Inc. BNTC | CVI Investments, Inc. | 88,235 5.800% | 88,235 (New Position) | Filing History |
| 2022-02-10 09:09 am Unchanged | 2021-12-31 | 13G | Benitec Biopharma Inc. BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 34,559 7.200% | 0 (Unchanged) | Filing History |
| 2022-02-10 09:07 am Unchanged | 2021-12-31 | 13G | Benitec Biopharma Inc. BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 34,559 7.200% | 0 (Unchanged) | Filing History |
| 2022-02-09 4:39 pm Purchase | 2021-12-31 | 13G | Benitec Biopharma Inc. BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 34,559 7.200% | 34,559 (New Position) | Filing History |
| 2022-02-08 4:31 pm Sale | 2021-12-31 | 13G | Benitec Biopharma Inc. BNTC | Hudson Bay Capital Management LP | 0 0.000% | -21,034 (Position Closed) | Filing History |